Reliability of immunocytochemical assay of estrogen receptors on breast cancer aspirates as a predictor of clinical response to hormone therapy
Ciatto, S.; Pacini, P.; Confortini, M.; Massimo, V.
Acta Cytologica 38(4): 666-667
1994
ISSN/ISBN: 0001-5547 PMID: 8042436 Document Number: 425374
Document emailed within 1 workday
Related Documents
McClelland, R.A.; Berger, U.; Miller, L.S.; Powles, T.J.; Jensen, E.V.; Coombes, R.C. 1986: Immunocytochemical assay for estrogen receptor: relationship to outcome of therapy in patients with advanced breast cancer Cancer Research 46(8 Suppl): 4241s-4243sCoombes, R.C.; Powles, T.J.; Berger, U.; Wilson, P.; McClelland, R.A.; Gazet, J.C.; Trott, P.A.; Ford, H.T. 1987: Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates Lancet 2(8561): 701-703
Rubens, R.D.; Hayward, J.L. 1980: Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer Cancer 46(12 Suppl): 2922-2924
Nardelli, G.B.; Lamaina, V.; Siliotti, F. 1986: Estrogen and progesterone receptors status in the prediction of response of breast cancer to endocrine therapy (preliminary report) European Journal of Gynaecological Oncology 7(3): 151-158
Berger, U.; Wilson, P.; Thethi, S.; McClelland, R.A.; Greene, G.L.; Coombes, R.C. 1989: Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors Cancer Research 49(18): 5176-5179
Di Lorenzo, D.; Zaniboni, A.; Simoncini, E.; Marpicati, P.; Montini, E.; Alghisi, A.; Gorni, F.; Marini, G. 1986: Estrogen and progesterone receptors in neoplastic cells of metastatic pleural effusion of breast carcinoma before and after tamoxifen therapy. Correlation with the clinical response Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 5(4): 232-236
Benítez-Bribiesca, L.; Guevara, R.; Ruiz, M.T.; Rodríguez-Cuevas, S.; Romero-Jaime, R. 1991: Evaluation of a simple semiquantitative assay for estrogen receptors in breast cancer Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 43(1): 31-36
Jensen, E.V.; Block, G.E.; Smith, S.; Kyser, K.; DeSombre, E.R. 1971: Estrogen receptors and breast cancer response to adrenalectomy National Cancer Institute Monograph 34: 55-70
Cocconi, G.; De Lisi, V.; Mori, P.; Bozzetti, C. 1982: Estrogen receptors and response to chemotherapy in advanced breast cancer Tumori 68(1): 67-71
Sauer, T.; Naess, O.; Kåresen, R.; Jacobsen, U.; Amlie, E.; Haug, E. 1994: Determination of estrogen receptors in aspirates from needle biopsies of breast carcinomas. Correlation to a biochemical method Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(9): 1053-1055
Dryzhak, V.I. 1989: Estrogen antagonists and inhibitors in hormone therapy of breast cancer Voprosy Onkologii 35(7): 771-778
Masood, S. 1988: Use of monoclonal antibodies in immunocytochemical localization of estrogen receptors in ovarian cancer Cancer Detection and Prevention 12(1-6): 283-290
Santen, R.J.; Pinkerton, J.; McCartney, C.; Petroni, G.R. 2001: Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy Journal of Clinical Endocrinology and Metabolism 86(1): 16-23
Tominaga, T. 1983: Histochemical and biochemical assays of estrogen receptors in breast cancer and significance of endocrine therapy Gan no Rinsho. Japan Journal of Cancer Clinics 29(6): 628-631
Balaton, A.L.; Coindre, J.M.; Collin, F.; Ettore, F.; Fiche, M.; Jacquemier, J.; Le Doussal, V.; Mandard, A.M.; Mathieu, M.C.; Migeon, C.; Simony-Lafontaine, J.; Treilleux, I.; Verriele, V.; Vilain, M.O.; Zafrani, B. 1996: Recommendations for the immunohistochemical evaluation of hormone receptors on paraffin sections of breast cancer. Study Group on Hormone Receptors using Immunohistochemistry FNCLCC/AFAQAP. National Federation of Centres to Combat Cancer/French Association for Quality Assurance in Pathology Annales de Pathologie 16(2): 144-148
Magnusson, C.; Weiderpass, E. 2001: Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer Lakartidningen 98(5): 418-421
McCarty, K.S.; Hiatt, K.B.; Budwit, D.A.; Cox, E.B.; Leight, G.; Reintgen, D.; Georgiade, G.; McCarty, K.S.; Siegler, H.F. 1984: Clinical response to hormone therapy correlated with estrogen receptor analyses. Biochemical v histochemical methods Archives of Pathology and Laboratory Medicine 108(1): 24-26
Nomura, Y.; Yamagata, J.; Kondo, H.; Takenaka, K. 1978: Endocrine adjuvant therapy with the antiestrogen, mepitiostane, inoperable breast cancer patients on the basis of estrogen receptor assay Gan 69(2): 281-282
Zeng, X.; Yao, Z. 2003: Relationship between expression of somatostatin receptors subtype 2 mRNA and estrogen and progesterone receptors in breast cancer Chinese Medical Journal 116(12): 1850-1853
Thorpe, S.M. 1987: Immunological quantitation of nuclear receptors in human breast cancer: relation to cytosolic estrogen and progesterone receptors Cancer Research 47(7): 1830-1835